The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. (Q45924302)

17 December 2017

title

The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. (English)

1 reference

17 December 2017

1 reference

1 reference

1 reference

8

1 reference

17 December 2017

Stefano Bartesaghi

object named as

S Bartesaghi

2

0 references

author name string

S Galavotti

1

1 reference

17 December 2017

D Faccenda

3

1 reference

17 December 2017

M Shaked-Rabi

4

1 reference

17 December 2017

S Sanzone

5

1 reference

17 December 2017

A McEvoy

6

1 reference

17 December 2017

D Dinsdale

7

1 reference

17 December 2017

S Brandner

9

1 reference

17 December 2017

M Campanella

10

1 reference

17 December 2017

R Grose

11

1 reference

17 December 2017

C Jones

12

1 reference

17 December 2017

P Salomoni

13

1 reference

17 December 2017

language of work or name

English

0 references

publication date

23 April 2012

1 reference

17 December 2017

published in

Oncogene

1 reference

17 December 2017

volume

32

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

699-712

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/onc.2012.111

exact match

0 references

cites work

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Glioblastoma stem-like cells give rise to tumour endothelium.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

The transcriptional network for mesenchymal transformation of brain tumours.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Tumor cell metabolism: cancer's Achilles' heel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

IDH mutations in glioma and acute myeloid leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Regulation of mammalian autophagy in physiology and pathophysiology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Autophagy for the avoidance of degenerative, inflammatory, infectious, and neoplastic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Autophagy in the cellular energetic balance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Selective autophagy in cancer development and therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

p62 at the crossroads of autophagy, apoptosis, and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

The double-edged sword of autophagy modulation in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Autophagy: an emerging target for cancer therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Targeted therapies and autophagy: new insights from chronic myeloid leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Chloroquine in glioblastoma--new horizons for an old drug

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Stage-specific effect of inhibition of autophagy on chemotherapy-induced cytotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Autophagy and Akt promote survival in glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Induction of autophagy in temozolomide treated malignant gliomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Network organization of the human autophagy system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

DRAM, a p53-induced modulator of autophagy, is critical for apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

DRAM links autophagy to p53 and programmed cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Drug development of MET inhibitors: targeting oncogene addiction and expedience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Pancreatic cancers require autophagy for tumor growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Mitochondrial fusion protects against neurodegeneration in the cerebellum.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Quality control of mitochondria: protection against neurodegeneration and ageing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Ras, autophagy and glycolysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Induction of autophagy during extracellular matrix detachment promotes cell survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Proteomic characterization of harvested pseudopodia with differential gel electrophoresis and specific antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Why do cancers have high aerobic glycolysis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

In vitro transformation of mesenchymal stem cells by oncogenic H-rasVal12.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1- 13C]pyruvate and 13C magnetic resonance spectroscopic imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

A Comparison of the Anaerobic Glycolysis of Human Brain and Glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Expression of facilitative glucose transporter isoforms in human brain tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Orchestration of lymphocyte chemotaxis by mitochondrial dynamics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Challenges in projecting clustering results across gene expression-profiling datasets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

Clinical implementation of the intrinsic subtypes of breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.111

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.111

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017